LifeLoc Technologies Inc (LCTC)

[pdicamillo1]

“We have committed additional personnel and new equipment resources to this effort, with the goal of placing beta test units in early 2024 with validation partners who have already been identified. We anticipate full commercialization to begin in 2024. Human trials have begun validating SpinDx detection of delta-9-THC at the detection limits of 10 ng/ml in real-world human samples. We intend to prioritize the acceleration of SpinDx even at the expense of short-term profitability, with research and development investments, including substantial validation testing, to be ongoing in 2023 and 2024.”